Fezolinetant
CRE-2025.427-T
Phase 2 small_molecule active
Quick answer
Fezolinetant for Vasomotor Symptoms is a Phase 2 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chinese University of Hong Kong
- Indication
- Vasomotor Symptoms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active